Shirley, NY, March 16, 2015 --(PR.com
)-- Creative Bioarray has successfully established hek 293 cells from a human primary embryonal kidney transformed by adenovirus type 5 (Ad 5) last month and by now has made those cells available in the worldwide market.
As a world leading biotech products provider, Creative Bioarray produces the world's most comprehensive list of research-use cells, including tumor cells, primary cells, stem cells and transformed cells. Since its foundation in 2005, the company has updated its cell products list for many times, along with its extension of business market and increasing annual sales.
“We are trying to meet everyone's needs of cells and become the largest cell repository in the world,” says Hannah Cole, the chief officer of Creative Bioarray.
The hek 293 cells are very easy to work with, which means they can be straightforwardly grow in culture and to transfect, and are very popular as hosts for gene expression. It can be used in many applications such as these experiments involve transfecting in a gene of interest, and then analyzing the expressed protein.
About hek 293 cells
Human Embryonic Kidney 293 cells, also known as HEK 293, HEK-293, 293 cells, or less precisely as HEK cells. This specific cell line are originally derived from human embryonic kidney cells grown in tissue culture and from still born animals.They are also used by the biotechnology industry to produce therapeutic proteins and viruses for gene therapy.
About Creative Bioarray
Creative Bioarray is a well-recognized biotech company based in New York, US. Propelled by integrity, expertise and the desire to simplify, improve, and accelerate research speed of the scientists, the company provides the highest standard quality research products and services including human and animal tissues, tissue array, microorganisms, cells, probe and cell services.